RYTM — Rhythm Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $6.06bn
- $5.83bn
- $189.76m
U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Wendy's, nLIGHT
Rhythm falls after US FDA delays decision on drug for brain damage-related obesity
US FDA extends review of Rhythm Pharma's drug for rare form of obesity (updated)
Brief: Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE (setmelanotide) for Patients with Acquired Hypothalamic Obesity
US FDA extends review of Rhythm Pharma's drug for rare form of obesity
Rhythm Pharma Q3 product revenue up 54% yr/yr on IMCIVREE sales
Brief: Rhythm Pharmaceuticals Announces FDA Acceptance Of sNDA For Setmelanotide In Acquired Hypothalamic Obesity
Live Markets: Prader-Willi drug sparks Wall Street interest in multi-billion dollar market, Leerink says
Rhythm Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Rhythm Pharmaceuticals Q2 Net Income USD -46.632 Million Vs. IBES Estimate USD -41.3 Million
Brief: Rhythm Pharmaceuticals Says Phase 2 Signal Trial Shows Bivamelagon Reduces BMI In Hypothalamic Obesity
U.S. STOCKS ON THE MOVE-Tesla, AbbVie, McDonald's
U.S. STOCKS ON THE MOVE-Copper miners, AMD, DallasNews
U.S. STOCKS ON THE MOVE-Huntington Ingalls, Nucor, Estee Lauder
Rhythm Pharma dips after boosted $175 mln equity raise
Brief: Rhythm Pharmaceuticals Announces Pricing Of Upsized Public Offering Of Common Stock
Rhythm Pharma unveils $150 mln equity offering after stock soars
U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx
U.S. STOCKS ON THE MOVE-Nvidia, Eli Lilly, Canopy Growth